Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$234.74 - $275.42 $469 - $550
2 Added 0.31%
649 $159,000
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $487 - $540
2 Added 0.31%
647 $167,000
Q4 2021

Feb 09, 2022

BUY
$230.08 - $250.94 $460 - $501
2 Added 0.31%
645 $158,000
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $232 - $256
1 Added 0.16%
643 $154,000
Q2 2021

Aug 06, 2021

SELL
$232.65 - $254.58 $13,493 - $14,765
-58 Reduced 8.29%
642 $152,000
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $9,051 - $10,018
39 Added 5.9%
700 $170 Million
Q4 2020

Feb 09, 2021

SELL
$221.92 - $245.94 $1,775 - $1,967
-8 Reduced 1.2%
661 $165 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $144,350 - $185,152
669 New
669 $151,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Baron Financial Group, LLC Portfolio

Follow Baron Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Financial Group, LLC with notifications on news.